Calithera Biosciences, Inc. (CALA) is a publicly traded company in the Unknown sector. Across all available filings, 25 corporate insiders have executed 186 transactions totaling $72.3M, demonstrating a bullish sentiment with $26.0M in net insider flow. The most recent transaction on Jan 27, 2023 involved a sale of 1,172 shares valued at $457.
No significant insider buying has been recorded for CALA in the recent period.
No significant insider selling has been recorded for CALA in the recent period.
Based on recent SEC filings, insider sentiment for CALA is bullish with an Insider Alignment Score of 68/100 and a net flow of $26.0M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at Calithera Biosciences, Inc. (CALA) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 25 insiders are actively trading CALA stock, having executed 186 transactions in the past 90 days. The most active insider is Venture Partners IX Lp Morgenthaler (Executive), who has made 2 transactions totaling $21.6M.
Get notified when executives and directors at CALA file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Jan 27, 2023 | Pakianathan Deepika | Executive | Sale | 1,172 | $0.39 | $457 | |
| Jan 27, 2023 | Pakianathan Deepika | Executive | Sale | 120,161 | $0.39 | $46.9K | |
| Jan 23, 2023 | Molineaux Christopher | Executive | Payment | 217 | $0.45 | $98 | |
| Jan 23, 2023 | Wong Stephanie | Executive | Payment | 317 | $0.45 | $143 | |
| Jan 23, 2023 | Molineaux Susan | Executive | Payment | 526 | $0.45 | $237 | |
| Jan 23, 2023 | Kuriakose Emil | Executive | Payment | 79 | $0.45 | $36 | |
| Jan 23, 2023 | Sjogren Eric | Executive | Payment | 279 | $0.45 | $126 | |
| Jan 21, 2022 | Kuriakose Emil | Executive | Payment | 666 | $0.49 | $326 | |
| Jan 21, 2022 | Sjogren Eric | Executive | Payment | 4,794 | $0.49 | $2.3K | |
| Jan 21, 2022 | Wong Stephanie | Executive | Payment | 5,586 | $0.49 | $2.7K | |
| Jan 21, 2022 | Parlati Francesco | Executive | Payment | 4,794 | $0.49 | $2.3K | |
| Jan 4, 2022 | Wong Stephanie | Executive | Payment | 18,077 | $0.66 | $11.9K | |
| Jan 4, 2022 | Sjogren Eric | Executive | Payment | 18,077 | $0.66 | $11.9K | |
| Jan 4, 2022 | Kuriakose Emil | Executive | Payment | 3,855 | $0.66 | $2.5K | |
| Jan 4, 2022 | Parlati Francesco | Executive | Payment | 18,077 | $0.66 | $11.9K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 47 | $49.2M | 53.8% |
Sale(S) | 29 | $23.1M | 25.3% |
Conversion(C) | 8 | $18.1M | 19.8% |
Exercise(M) | 48 | $687.8K | 0.8% |
Payment(F) | 20 | $350.7K | 0.4% |
Award(A) | 28 | $0 | 0.0% |
Gift(G) | 4 | $0 | 0.0% |
Other(J) | 2 | $0 | 0.0% |
Insiders at Calithera Biosciences, Inc. are accumulating shares at an accelerated pace. With 25 insiders making 186 transactions totaling $49.2M in purchases versus $23.1M in sales, the net buying activity of $26.0M signals strong executive confidence. Venture Partners IX Lp Morgenthaler (Executive) leads the buying activity with $21.6M in transactions across all time.